(Q45886869)

17 December 2017

title

Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression (English)

1 reference

17 December 2017

0 references

Fong CL

1

1 reference

17 December 2017

Mok CL

series ordinal

2

1 reference

17 December 2017

Hui KM

series ordinal

3

1 reference

17 December 2017

publication date

1 February 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

245-256

1 reference

17 December 2017

Origin, precursors and differentiation of mouse dendritic cells

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Current status of dendritic cell immunotherapy of malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Generation of potent and specific cellular immune responses via in vivo stimulation of dendritic cells by pNGVL3-hFLex plasmid DNA and immunogenic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

The immunobiology of muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

MUC1 immunobiology: from discovery to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

A new foreign policy: MHC class I molecules monitor the outside world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Unexpectedly, induction of cytotoxic T lymphocytes enhances the humoral response after DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Immunization with DNA through the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Cytotoxic T lymphocytes against a soluble protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

Flt3 ligand induces tumor regression and antitumor immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Cellular mucins: targets for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302639

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302639

1 reference

17 December 2017

Dimensions Publication ID

1008571162

0 references

1 reference

17 December 2017